Core Viewpoint - Rosen Law Firm is reminding purchasers of Varonis Systems, Inc. common stock of the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during a specified class period [1][2]. Group 1: Class Action Details - Investors who purchased Varonis common stock between February 4, 2025, and October 28, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 9, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Varonis - The lawsuit alleges that Varonis made materially false and misleading statements regarding its ability to maintain Annual Recurring Revenue (ARR) projections while transitioning customers to a software-as-a-service (SaaS) model [5]. - It is claimed that Varonis was not adequately prepared to convince existing users of the benefits of the SaaS offering, leading to reduced ARR growth potential [5]. - The lawsuit asserts that the misleading statements about Varonis' business operations and prospects resulted in investor damages when the true situation became known [5].

Core Viewpoint - Transocean Ltd. reported its financial results for the fourth quarter and full year of 2025, highlighting significant improvements in operational efficiency and financial restructuring, despite a substantial net loss attributable to controlling interest. Financial Performance Summary - Contract drilling revenues for 2025 reached $3.965 billion, a 13% increase from $3.524 billion in 2024 [7] - Adjusted EBITDA was $1.37 billion, up 19% from $1.148 billion in 2024, with an adjusted EBITDA margin of 34.6% [5][7] - Net loss attributable to controlling interest was $2.915 billion, translating to a basic and diluted loss per share of $3.04 [7][21] - Cash flows from operations were $749 million, an increase of 68% compared to the previous year [7] - Free cash flow improved to $626 million, up from $193 million in 2024 [7] Operational Highlights - The company achieved a revenue efficiency of 96.5%, up from 94.5% in 2024 [7] - The total principal amount of debt was reduced to $5.686 billion, down $1.258 billion or 18% [7] - The company added $839 million in contract backlog at a weighted average dayrate of $453,000 [7] Fourth Quarter Performance - In Q4 2025, contract drilling revenues were $1.043 billion, a 1.5% increase from the prior quarter [11] - Net income attributable to controlling interest for Q4 was $25 million, compared to a loss of $1.923 billion in Q3 [11] - Adjusted EBITDA for Q4 was $385 million, slightly down from $397 million in Q3 [11] Future Outlook - For Q1 2026, contract drilling revenues are expected to be between $1.020 billion and $1.050 billion, with full-year guidance set at $3.800 billion to $3.950 billion [10] - The company aims to maintain a revenue efficiency of 96.5% for the full year of 2026 [10] Strategic Initiatives - The company announced a definitive agreement to combine with Valaris, which is expected to enhance fleet capabilities and financial flexibility [5] - The primary objective for 2026 is to exceed customer expectations by delivering safe and efficient operations [4]

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December 31, 2025. FY 2025 key results1 Group performance2: Double-digit revenue growth and positive adjusted operating cash flow Revenue of US$803.8 million, up by 56%3 and achieving upsized full year guidance4.US$157.1 million invested in research and development (R&D) product development for late-stage therapeutics ...

Core Viewpoint - Imperial Metals Corporation reported significant increases in metal production from the Red Chris mine in 2025, exceeding production guidance for both copper and gold [1][2]. Production Summary - In 2025, Red Chris produced 93,101,213 pounds of copper and 92,429 ounces of gold, marking increases from 85,320,618 pounds of copper and 59,811 ounces of gold in 2024 [1]. - The company's 30% share of Red Chris mine production for 2025 was 27,930,364 pounds of copper and 27,729 ounces of gold, up from 25,596,185 pounds of copper and 17,943 ounces of gold in 2024 [2]. Future Outlook - Newmont Mining Corporation's guidance for Red Chris mine production in 2026 is projected to be between 60 million to 66 million pounds of copper and 47,500 to 52,500 ounces of gold, indicating a decrease in production due to mining lower grade ore [3]. - The feasibility study for a block cave expansion operation at Red Chris is progressing, with completion and joint venture approval expected in the second half of 2026 [2]. Company Overview - Imperial Metals is based in Vancouver and operates the Mount Polley mine, Huckleberry mine, and holds a 30% interest in the Red Chris mine, along with 23 greenfield exploration properties in British Columbia [5].

Group 1 - The Company, D. Boral Acquisition I Corp., will allow holders of its initial public offering units to separately trade Class A ordinary shares and warrants starting February 25, 2026 [1][2] - The separated Class A ordinary shares and warrants will trade on The Nasdaq Global Market under the symbols "DBCA" and "DBCAW," while units that remain unseparated will trade under the symbol "DBCAU" [2] - A registration statement on Form S-1 for these securities was declared effective by the SEC on January 30, 2026, and the offering was made only by means of a prospectus [3] Group 2 - The Company was formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [5] - The Company intends to pursue acquisition opportunities in various sectors, particularly focusing on technology, healthcare, and logistics, where it believes its management teams' expertise will provide a competitive advantage [5]

Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation for allegedly making false and misleading statements regarding its business operations and partnerships, particularly concerning ENTRA1 Energy LLC's lack of experience in nuclear power generation [2][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased NuScale Class A common stock between May 13, 2025, and November 6, 2025, with a deadline of April 20, 2026, for investors to apply as lead plaintiffs [2]. - Allegations include that NuScale misrepresented ENTRA1's capabilities, claiming it had never built or operated significant projects in nuclear power, which exposed NuScale's commercialization strategy to undisclosed risks [3]. Group 2: Next Steps for Investors - Investors who suffered losses and wish to learn more about their rights or the lawsuit can contact the law firm Bragar Eagel & Squire, P.C. for further information [4]. Group 3: About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation, including securities and commercial cases [5].

Core Viewpoint - Altisource Portfolio Solutions S.A. is set to report its earnings for the fourth quarter of 2025 on March 4, 2026, with a press release and presentation available on its Investor Relations website [1]. Group 1: Earnings Report - The earnings report for the fourth quarter of 2025 will be released on March 4, 2026 [1]. - A conference call to discuss the results will take place at 8:30 a.m. EST on the same day [2]. - A replay of the conference call will be accessible approximately two hours after the call and will remain available for about 30 days [2]. Group 2: Company Overview - Altisource Portfolio Solutions S.A. operates as an integrated service provider and marketplace for the real estate and mortgage industries [3]. - The company combines operational excellence with innovative services and technologies to address the demands of changing markets [3].

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until March 2, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff over ...

Core Insights - Relay Therapeutics is a clinical-stage company focused on developing small molecule precision medicine for cancer and genetic diseases [2] - The company will report its fourth quarter and full year 2025 financial results on February 26, 2026 [1] Company Overview - Relay Therapeutics utilizes its Dynamo® platform, which combines advanced computational and experimental methods to target previously difficult-to-drug proteins [2] - The lead clinical asset, zovegalisib, is the first pan-mutant selective PI3Kα inhibitor in clinical development, currently in Phase 3 trials for HR+/HER2- metastatic breast cancer [2] - Zovegalisib is also being studied for PI3Kα-driven vascular anomalies and the company has additional programs targeting NRAS-driven solid tumors and Fabry disease [2]

Core Insights - Sienna Senior Living Inc. reported strong financial results for 2025, driven by organic growth, strategic acquisitions, and new developments, with expectations to maintain growth momentum in 2026 [3][4][18] Financial Performance - Revenue for 2025 exceeded $1.0 billion, marking a 15.0% increase year-over-year [4][17] - Same Property Net Operating Income (NOI), excluding One-Time Items, rose by 10.1% year-over-year to $47.4 million in Q4 2025 [4][17] - Adjusted Funds from Operations (AFFO), excluding One-Time Items, increased by 19.8% year-over-year in Q4 2025, reaching $27.9 million [4][17] - The AFFO Payout Ratio, excluding One-Time Items, decreased to 80.7% in Q4 2025 from 83.1% in Q4 2024 [4][17] Portfolio Expansion - In 2025, Sienna expanded its portfolio through acquisitions and developments totaling approximately $803 million [19] - The company completed several acquisitions, including properties in Greater Vancouver, Calgary, and Ottawa, with a total investment of $594.7 million [5][7] - A redevelopment project for a 448-bed Long-Term Care facility in Toronto is anticipated to start construction in the second half of 2026, with an estimated cost of $250 million [9] Occupancy and Operational Metrics - Average Same Property Occupancy in the retirement segment increased by 180 basis points year-over-year to 94.7% in Q4 2025, further rising to 95.2% in January 2026 [4][20] - The Retirement segment experienced a 15.4% increase in NOI year-over-year in Q4 2025, while the Long-Term Care (LTC) segment saw a 5.6% increase [4][17] Future Outlook - The company expects to leverage favorable supply/demand fundamentals in Canadian senior living to continue growth in 2026 [3][18] - Key targets for 2026 include achieving over 95% occupancy in the retirement segment and over 10% NOI growth [23] - Sienna plans to optimize its existing portfolio through asset optimization initiatives to unlock substantial NOI growth [22]